Image Ben Hargreaves Market Access Is the UK’s healthcare spending drop sustainable? The UK’s health system has been under pressure to manage costs whilst still delivering a reliable service. Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution? R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control. Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs. Load more results
Market Access Is the UK’s healthcare spending drop sustainable? The UK’s health system has been under pressure to manage costs whilst still delivering a reliable service.
Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?
R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.
Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.
News Is Martin Makary Trump's pick for FDA Commissioner? US President-elect Donald Trump is reported to be considering the nomination of Johns Hopkins surgeon and writer Martin Makary to lead the FDA
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
